These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16204334)

  • 21. Medicare: looking for pareto optimal changes.
    Christensen S
    Inquiry; 1992; 29(4):426-39. PubMed ID: 1473866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shaping the future of Medicare.
    Davis K
    Health Serv Res; 1999 Apr; 34(1 Pt 2):295-306. PubMed ID: 10199676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analytic dimensions of a prescription-medication benefit in medicare.
    Vogel RJ; Cox ER
    Clin Ther; 2000 Apr; 22(4):470-93. PubMed ID: 10823367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How beneficiaries fare under the new Medicare drug bill.
    Moon M
    Issue Brief (Commonw Fund); 2004 Jun; (730):1-16. PubMed ID: 15176395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug politics in the USA].
    Gaier N
    Cas Lek Cesk; 2001 Nov; 140(22):701-3. PubMed ID: 11789060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicare supplemental insurance (Medigap).
    Stein N
    Issue Brief Cent Medicare Educ; 2003; 4(6):1-6. PubMed ID: 14503483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How asset tests block low-income Medicare beneficiaries from needed benefits.
    Summer L; Thompson L
    Issue Brief (Commonw Fund); 2004 May; (727):1-12. PubMed ID: 15171232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Savings from drug discount cards: relief for Medicare beneficiaries?
    Cubanski J; Frank RG; Epstein AM
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-198-209. PubMed ID: 15451980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Part I--Medicare prescription drug coverage (Part D): the promise.
    Witten B
    Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of supplemental medical and prescription drug coverage on health care spending for Medicare beneficiaries with cancer.
    Erten MZ; Davidoff AJ; Zuckerman IH; Shaffer T; Dougherty JS; Ke X; Stuart B
    Value Health; 2014; 17(1):15-21. PubMed ID: 24438713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost minimization of medicare part D prescription drug plan expenditures.
    Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR
    Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare Part D: how do vulnerable beneficiaries fare?
    Summer L; Nemore P; Finberg J
    Issue Brief (Commonw Fund); 2008 Apr; 35():1-11. PubMed ID: 18536146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit adequacy among elderly Social Security retired-worker beneficiaries and the SSI federal benefit rate.
    Rupp K; Strand A; Davies P; Sears J
    Soc Secur Bull; 2007; 67(3):29-51. PubMed ID: 18605217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicare Part D: practical practice information for healthcare providers.
    Moczygemba LR
    J Am Acad Nurse Pract; 2006 Oct; 18(10):457-62. PubMed ID: 16999710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing Medicare prescription drug plans in four states: balancing cost and access.
    Heaton E; Carino T; Dix H
    Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicare program; Medicare prescription drug benefit; interpretation. Final rule; interpretation.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Mar; 70(53):13397-400. PubMed ID: 15786588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Funding savings needed for health expenses for persons eligible for Medicare.
    Fronstin P; Salisbury D; VanDerhei J
    EBRI Issue Brief; 2010 Dec; (351):1-14. PubMed ID: 21319573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
    Polinski JM; Mohr PE; Johnson L
    Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving with Medicare: an approach to retirement strategy.
    Habliston C; Hanrahan M
    Benefits Q; 2006; 22(3):32-6. PubMed ID: 17039820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why more cost-sharing won't slow Medicare spending.
    Chulis GS; Eppig FJ; Hogan MO; Waldo DR; Arnett RH
    J Am Health Policy; 1993; 3(4):15-20. PubMed ID: 10127492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.